BusinessCyclacel Presents Identification of Sensitive Target Indications and Synergistic Drug Combinations for Novel PLK1 Inhibitor CYC140By Nasdaq OMXApr 4, 2017, 5:00 PM UTC
BusinessTonix Pharmaceuticals Completes $8 Million Public Offering of Common StockBy Nasdaq OMXApr 4, 2017, 3:30 PM UTC
BusinessNeoTherma Oncology Announces FDA Granted Its Vectron Thermal Device for Treatment of Pancreatic Cancer Breakthrough Device Designation within Expedited Access PathwayBy Nasdaq OMXApr 4, 2017, 2:06 PM UTC
BusinessInterim Phase 2 Data Demonstrate Robust Response Rate with Indoximod in Combination with Keytruda® (pembrolizumab) for Patients with Advanced Melanoma at AACR PlenaryBy Nasdaq OMXApr 4, 2017, 12:30 PM UTC
BusinessBellicum Pharmaceuticals Announces Late-Breaking Presentation of Dual-Switch CAR-T / TCR Technology at AACRBy Nasdaq OMXApr 4, 2017, 12:01 PM UTC
BusinessBellicum Pharmaceuticals Announces Late-Breaking Presentation of Dual-Switch CAR-T / TCR Technology at AACRBy Nasdaq OMXApr 4, 2017, 12:01 PM UTC
BusinessAtara Bio Expands Management Team, Appoints Joe Newell as Executive Vice President, Chief Technical Operations OfficerBy Nasdaq OMXApr 3, 2017, 12:01 PM UTC
BusinessMadrigal Pharmaceuticals Reports 2016 Fourth Quarter and Year-End Financial Results, Reviews Key Corporate Achievements and Provides Update on Lead Clinical-stage Compound, MGL-3196By Nasdaq OMXApr 3, 2017, 11:30 AM UTC
